EDITORIAL
BioBoard
Australia • Australia Lifts Transplant Rate • Tamarind Derivative Repairs Damaged Brain Cells • High Hopes for Ross River Virus Vaccine • Genetic Link to Risk of Developing Bone Disease • Edible Vaccine in the Works
China • China Mulls New Mental Health Law • University of Pennsylvania Pairs up with Chinese Academy of Sciences for Neuroimaging
India • Vaccine Tests for Brain Virus
Korea • New Technique Makes Artificial Bones More Natural • Scientists Develop Magnetic Nanoparticles that Kill Cancer Cells
Singapore • IE Singapore Forms Biomedical R&D Consortium
Vietnam • Fatty Liver Disease on the Rise Among Youth Other Regions • New Clues to How Cancer Spreads • Scientists Find Genes Linked to Migraines • New Drug Makes Hearts Repair Themselves Feature • The clinical application of stem cells in hematopoietic disease • Use of pluripotent stem cells and their differentiated products in pharmacological drug discovery and safety testing • Messages from the nucleus: Insights into Aging • inStem: The Institute for Stem Cell Biology and Regenerative Medicine Review • Why Invest in Life Sciences and Healthcare? Inside Industry • ADDF Supports Axxam to Develop Therapeutics for Alzheimer’s • Epitomics Signs Agreement with Bayer for Antibody Technology • Sirnaomics Partners Guangdong Zhongsheng to Dvelop siRNA Therapeutics • Jubilant, Endo Achieve Late Stage Discovery Milestone • Merck and Hanwha Chemical Corporation Establish Global Strategic Collaboration for Biosimilar • SIOGEN Awarded ‘Most Innovative Biotech in Asia' • GENEWIZ, Inc. and Biomatters Announce Strategic Partnership to Align DNA-Based Services and Analysis Software • Invida Launches Atopiclair™, a Treatment for Atopic Dermatitis Symptoms • Accenture Implements Nationwide Electronic Health Record System in Singapore • A*STAR & Olympus Singapore Establish Microscopy Suite to Study Human Diseases at the Nano-level Research and Findings • Singapore Scientists Discover How to Control Fate of Stem Cells Without the Risk of Developing Cancer Cells • IMRE Scientists Develop First-of-its-kind Hydrogel and New Mix-and-match Block Copolymer ‘Smart’ Biomaterials • Mechanism for Stress-induced Epigenetic Inheritance Uncovered in New Study Conference Calendar
Feature • The clinical application of stem cells in hematopoietic disease • Use of pluripotent stem cells and their differentiated products in pharmacological drug discovery and safety testing • Messages from the nucleus: Insights into Aging • inStem: The Institute for Stem Cell Biology and Regenerative Medicine
Review • Why Invest in Life Sciences and Healthcare?
Inside Industry • ADDF Supports Axxam to Develop Therapeutics for Alzheimer’s • Epitomics Signs Agreement with Bayer for Antibody Technology • Sirnaomics Partners Guangdong Zhongsheng to Dvelop siRNA Therapeutics • Jubilant, Endo Achieve Late Stage Discovery Milestone • Merck and Hanwha Chemical Corporation Establish Global Strategic Collaboration for Biosimilar • SIOGEN Awarded ‘Most Innovative Biotech in Asia' • GENEWIZ, Inc. and Biomatters Announce Strategic Partnership to Align DNA-Based Services and Analysis Software • Invida Launches Atopiclair™, a Treatment for Atopic Dermatitis Symptoms • Accenture Implements Nationwide Electronic Health Record System in Singapore • A*STAR & Olympus Singapore Establish Microscopy Suite to Study Human Diseases at the Nano-level
Research and Findings • Singapore Scientists Discover How to Control Fate of Stem Cells Without the Risk of Developing Cancer Cells • IMRE Scientists Develop First-of-its-kind Hydrogel and New Mix-and-match Block Copolymer ‘Smart’ Biomaterials • Mechanism for Stress-induced Epigenetic Inheritance Uncovered in New Study
Conference Calendar
"The views expressed here does not necessarily reflect the views of Asia Pacific Biotech News or its staff." Copyright © 2013 World Scientific Publishing Co. All rights reserved.
